Living in modern biopolitical risk culture might be seen as synonymous with living in prognosis time, in the sense that risk of illness is endlessly forecast (prognosticated) in the broad social arena. ‘Safety,’ in this context, is framed as the anticipatory guarding against risk or disease in order to ‘make live.’ Thinking of risk and safety in these ways is limited, however, in that the prognosis cannot account for the individual’s life or death drama. This paper asks: how are we (...) to understand the constellation of risk, prognosis, and safety in relation to ‘the subject in breast cancer prognosis’? (shrink)

This paper examines cancer through the lens of abjection. While cancer can be understood as an abject lifeform, we explore what we name the abject ontologies created through both cancer detection technologies/practices and cancer treatment, specifically the drug combination Adriamycin and Cytoxan. We ask: what are the abject ontologies produced through living with and living on from cancer diagnosis and treatment? Our concern is to map how cancer undoes our supposedly stable categories inherited from modernist logic, challenges our very ideas (...) of what it means to be human, and demands an ethical reorientation of public cancer discourse. (shrink)

This book project intends to serve as a course adoption book unpacking theories of biopolitical life-making and death-making, with chapters dedicated to specific objects that ostensibly affirm life (and argue for life's inextricable links to capital), but that ultimately reify a politics of death and erasure. Specific objects, such as the pink Kommen Foundation-branded handgun, the 'super user' of health care resources, and fat cells allow the authors to discuss the political junctures at which determinations of healthy and unhealthy, life (...) and death, are made. (shrink)